explore -WSS

explore

author：focus 2025-10-01 23:04:01 - browse：3375

Pfizer plans to exit a major biotechnology industry trade association. Cindy Ord/Getty Images for Pfizer/BioNTech

WASHINGTON — Pfizer has decided to leave the Biotechnology Innovation Organization, according to two sources familiar with the planning.

The departure is a blow to BIO, which represents members ranging from small biotech startups to massive pharmaceutical companies. The group on Tuesday announced its new CEO, rare disease advocate and biotech executive John Crowley.

“The economic situation for the industry is difficult indeed and we of course are disappointed that any company would be forced to take a break from its BIO membership. We certainly hope that when economic conditions improve, we can welcome those companies back and welcome new members to join us as well, but it in no way affects our mission of protecting patients and medical innovation in the United States,” said BIO’s Chief Public Affairs and Marketing Officer Rich Masters. Masters said he wouldn’t comment on the status of any particular member.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： In his State of the Union, Biden takes clear aim at 'Big Pharma'

Wikipedia

WSS

Sen. Paul opposes bill to ban Chinese biotechs

Structure Therapeutics oral GLP

A new initiative will help leaders fight the next pandemic

A new initiative will help leaders fight the next pandemic

UnitedHealth CEO's Medicaid comments send insurer stocks diving

NEJM study link tiny plastics in blood vessels to heart problems

Wikipedia

explore

Wikipedia

23andMe had bad news about my health. I wish a person had delivered it

With psoriasis trial ahead, Alumis raises $259 million

Dobbs anniversary: the lost opportunity of abortion as health care

An outdated Medicare rule harms dementia patients with anxiety

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

The problem with charging patients to message their doctors

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Amylyx ALS drug fails large clinical trial

New air purifier tech could be key to improving indoor air quality

BD to buy Edwards patient monitoring unit for $4.2 billion

entertainment

CMS got Medicare Advantage quality rating wrong, judge rules

RSV shot was 90% effective at preventing hospitalizations in kids

Take antibiotics after sex, CDC recommends for certain risk groups

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

For pregnant people, addiction treatment shouldn't mean a call to child protective services

UnitedHealth quietly bought dozens of outpatient centers

Wikipedia

leisure time

hotspot

Wikipedia